ID HXK1_RAT Reviewed; 918 AA. AC P05708; DT 01-NOV-1988, integrated into UniProtKB/Swiss-Prot. DT 30-MAY-2000, sequence version 4. DT 02-SEP-2026, entry version 202. DE RecName: Full=Hexokinase-1 {ECO:0000305}; DE EC=2.7.1.1 {ECO:0000269|PubMed:13211595, ECO:0000269|PubMed:3579310, ECO:0000269|PubMed:5871820}; DE AltName: Full=Brain form hexokinase {ECO:0000303|PubMed:2704734}; DE AltName: Full=Hexokinase type I {ECO:0000303|PubMed:3579310}; DE Short=HK I {ECO:0000303|PubMed:3579310}; DE AltName: Full=Hexokinase-A {ECO:0000303|PubMed:5871820}; GN Name=Hk1 {ECO:0000312|RGD:2796}; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-466. RC TISSUE=Brain; RX PubMed=2704734; DOI=10.1073/pnas.86.8.2563; RA Schwab D.A., Wilson J.E.; RT "Complete amino acid sequence of rat brain hexokinase, deduced from the RT cloned cDNA, and proposed structure of a mammalian hexokinase."; RL Proc. Natl. Acad. Sci. U.S.A. 86:2563-2567(1989). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 467-918. RC TISSUE=Brain; RX PubMed=3277968; DOI=10.1016/s0021-9258(18)69058-1; RA Schwab D.A., Wilson J.E.; RT "The complete amino acid sequence of the catalytic domain of rat brain RT hexokinase, deduced from the cloned cDNA."; RL J. Biol. Chem. 263:3220-3224(1988). RN [3] RP SEQUENCE REVISION. RA Wilson J.E.; RL Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases. RN [4] RP PROTEIN SEQUENCE OF 597-617; 625-636 AND 802-816. RC TISSUE=Brain; RX PubMed=3631958; DOI=10.1016/0003-9861(87)90536-4; RA Schirch D.M., Wilson J.E.; RT "Rat brain hexokinase: amino acid sequence at the substrate hexose binding RT site is homologous to that of yeast hexokinase."; RL Arch. Biochem. Biophys. 257:1-12(1987). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21. RC STRAIN=Sprague-Dawley; TISSUE=Liver; RA White J.A., Liu W., Wilson J.E.; RL Submitted (DEC-1995) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 221-246 AND 631-668. RA White J.A., Wilson J.E.; RL Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases. RN [7] RP FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=13211595; DOI=10.1016/s0021-9258(18)65384-0; RA Sols A., Crane R.K.; RT "Substrate specificity of brain hexokinase."; RL J. Biol. Chem. 210:581-595(1954). RN [8] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=5871820; DOI=10.1016/0006-291x(64)90038-5; RA Gonzalez C., Ureta T., Sanchez R., Niemeyer H.; RT "Multiple molecular forms of ATP:hexose 6-phosphotransferase from rat RT liver."; RL Biochem. Biophys. Res. Commun. 16:347-352(1964). RN [9] RP REVIEW. RX PubMed=7044667; DOI=10.1016/0305-0491(82)90461-8; RA Ureta T.; RT "The comparative isozymology of vertebrate hexokinases."; RL Comp. Biochem. Physiol. 71:549-555(1982). RN [10] RP FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=3579310; DOI=10.1016/0003-9861(87)90116-0; RA Schirch D.M., Wilson J.E.; RT "Rat brain hexokinase: location of the substrate hexose binding site in a RT structural domain at the C-terminus of the enzyme."; RL Arch. Biochem. Biophys. 254:385-396(1987). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY, AND TISSUE SPECIFICITY. RX PubMed=19423663; DOI=10.1530/rep-09-0052; RA Khan S.A., Suryawanshi A.R., Ranpura S.A., Jadhav S.V., Khole V.V.; RT "Identification of novel immunodominant epididymal sperm proteins using RT combinatorial approach."; RL Reproduction 138:81-93(2009). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22673903; DOI=10.1038/ncomms1871; RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., RA Olsen J.V.; RT "Quantitative maps of protein phosphorylation sites across 14 different rat RT organs and tissues."; RL Nat. Commun. 3:876-876(2012). RN [13] RP X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH GLUCOSE AND RP GLUCOSE-6-PHOSPHATE. RX PubMed=9665168; DOI=10.1038/811; RA Mulichak A.M., Wilson J.E., Padmanabhan K., Garavito R.M.; RT "The structure of mammalian hexokinase-1."; RL Nat. Struct. Biol. 5:555-560(1998). CC -!- FUNCTION: Catalyzes the phosphorylation of various hexoses, such as D- CC glucose, D-glucosamine, D-fructose, D-mannose and 2-deoxy-D-glucose, to CC hexose 6-phosphate (D-glucose 6-phosphate, D-glucosamine 6-phosphate, CC D-fructose 6-phosphate, D-mannose 6-phosphate and 2-deoxy-D-glucose 6- CC phosphate, respectively) (PubMed:13211595, PubMed:3579310, CC PubMed:5871820). Mediates the initial step of glycolysis by catalyzing CC phosphorylation of D-glucose to D-glucose 6-phosphate (PubMed:13211595, CC PubMed:5871820). Involved in innate immunity and inflammation by acting CC as a pattern recognition receptor for bacterial peptidoglycan (By CC similarity). When released in the cytosol, N-acetyl-D-glucosamine CC component of bacterial peptidoglycan inhibits the hexokinase activity CC of HK1 and causes its dissociation from mitochondrial outer membrane, CC thereby activating the NLRP3 inflammasome (By similarity). CC {ECO:0000250|UniProtKB:P19367, ECO:0000269|PubMed:13211595, CC ECO:0000269|PubMed:3579310, ECO:0000269|PubMed:5871820}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a D-hexose + ATP = a D-hexose 6-phosphate + ADP + H(+); CC Xref=Rhea:RHEA:22740, ChEBI:CHEBI:4194, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:229467, ChEBI:CHEBI:456216; CC EC=2.7.1.1; Evidence={ECO:0000269|PubMed:13211595, CC ECO:0000269|PubMed:3579310, ECO:0000269|PubMed:5871820}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22741; CC Evidence={ECO:0000269|PubMed:13211595, ECO:0000269|PubMed:3579310, CC ECO:0000269|PubMed:5871820}; CC -!- CATALYTIC ACTIVITY: CC Reaction=D-fructose + ATP = D-fructose 6-phosphate + ADP + H(+); CC Xref=Rhea:RHEA:16125, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:37721, ChEBI:CHEBI:61527, ChEBI:CHEBI:456216; EC=2.7.1.1; CC Evidence={ECO:0000269|PubMed:13211595, ECO:0000269|PubMed:5871820}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16126; CC Evidence={ECO:0000269|PubMed:13211595, ECO:0000269|PubMed:5871820}; CC -!- CATALYTIC ACTIVITY: CC Reaction=D-glucose + ATP = D-glucose 6-phosphate + ADP + H(+); CC Xref=Rhea:RHEA:17825, ChEBI:CHEBI:4167, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61548, ChEBI:CHEBI:456216; EC=2.7.1.1; CC Evidence={ECO:0000269|PubMed:13211595, ECO:0000269|PubMed:5871820}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17826; CC Evidence={ECO:0000269|PubMed:5871820}; CC -!- CATALYTIC ACTIVITY: CC Reaction=D-mannose + ATP = D-mannose 6-phosphate + ADP + H(+); CC Xref=Rhea:RHEA:11028, ChEBI:CHEBI:4208, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:58735, ChEBI:CHEBI:456216; EC=2.7.1.1; CC Evidence={ECO:0000269|PubMed:13211595}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11029; CC Evidence={ECO:0000269|PubMed:13211595}; CC -!- CATALYTIC ACTIVITY: CC Reaction=D-glucosamine + ATP = D-glucosamine 6-phosphate + ADP + H(+); CC Xref=Rhea:RHEA:10948, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:58723, ChEBI:CHEBI:58725, ChEBI:CHEBI:456216; EC=2.7.1.1; CC Evidence={ECO:0000250|UniProtKB:P19367}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10949; CC Evidence={ECO:0000250|UniProtKB:P19367}; CC -!- ACTIVITY REGULATION: Hexokinase is an allosteric enzyme inhibited by CC its product D-glucose 6-phosphate. Hexokinase activity is inhibited by CC N-acetyl-D-glucosamine. {ECO:0000250|UniProtKB:P19367}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=44 uM for D-glucose {ECO:0000269|PubMed:5871820}; CC KM=3.1 mM for D-fructose {ECO:0000269|PubMed:5871820}; CC KM=0.42 mM for ATP {ECO:0000269|PubMed:5871820}; CC -!- PATHWAY: Carbohydrate metabolism; hexose metabolism. CC {ECO:0000305|PubMed:5871820}. CC -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3- CC phosphate and glycerone phosphate from D-glucose: step 1/4. CC {ECO:0000305|PubMed:5871820}. CC -!- SUBUNIT: Monomer (By similarity). Interacts with RABL2/RABL2A; binds CC preferentially to GTP-bound RABL2 (By similarity). Interacts with CC VDAC1. The HK1-VDAC1 complex interacts with ATF2 (By similarity). CC Interacts (via N-terminal spermatogenic cell-specific region) with PFKM CC (via C-terminus) (By similarity). Interacts with SMAD5 (By similarity). CC {ECO:0000250|UniProtKB:P17710, ECO:0000250|UniProtKB:P19367}. CC -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane CC {ECO:0000250|UniProtKB:P19367}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:P19367}. Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:P19367}. Note=The mitochondrial-binding peptide CC (MBP) region promotes association with the mitochondrial outer CC membrane. Dissociates from the mitochondrial outer membrane following CC inhibition by N-acetyl-D-glucosamine, leading to relocation to the CC cytosol. {ECO:0000250|UniProtKB:P19367}. CC -!- TISSUE SPECIFICITY: Expressed in flagella of epididymal sperm. CC {ECO:0000269|PubMed:19423663}. CC -!- DOMAIN: The N- and C-terminal halves of this hexokinase contain a CC hexokinase domain. The catalytic activity is associated with the C- CC terminus while regulatory function is associated with the N-terminus. CC Each domain can bind a single D-glucose and D-glucose 6-phosphate CC molecule. {ECO:0000250|UniProtKB:P19367}. CC -!- SIMILARITY: Belongs to the hexokinase family. {ECO:0000255|PROSITE- CC ProRule:PRU01084, ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J04526; AAC20075.1; -; mRNA. DR EMBL; U27319; AAC52945.1; -; Genomic_DNA. DR EMBL; U89160; AAB71376.1; -; Genomic_DNA. DR EMBL; U89158; AAB71374.1; -; Genomic_DNA. DR PIR; A32521; A32521. DR PIR; B32521; B32521. DR PIR; C32521; C32521. DR PIR; C59226; C59226. DR RefSeq; NP_036866.2; NM_012734.2. DR PDB; 1BG3; X-ray; 2.80 A; A/B=1-918. DR AlphaFoldDB; P05708; -. DR SMR; P05708; -. DR BioGRID; 247135; 6. DR FunCoup; P05708; 778. DR IntAct; P05708; 4. DR MINT; P05708; -. DR STRING; 10116.ENSRNOP00000066611; -. DR ChEMBL; CHEMBL4783; -. DR GlyGen; P05708; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P05708; -. DR PhosphoSitePlus; P05708; -. DR jPOST; P05708; -. DR PaxDb; 10116-ENSRNOP00000066611; -. DR DNASU; 25058; -. DR GeneID; 25058; -. DR KEGG; rno:25058; -. DR AGR; RGD:2796; -. DR CTD; 3098; -. DR RGD; 2796; Hk1. DR InParanoid; P05708; -. DR PhylomeDB; P05708; -. DR BRENDA; 2.7.1.1; 5301. DR SABIO-RK; P05708; -. DR UniPathway; UPA00109; UER00180. DR UniPathway; UPA00242; -. DR EvolutionaryTrace; P05708; -. DR PRO; PR:P05708; -. DR Proteomes; UP000002494; Unplaced. DR GO; GO:0005901; C:caveola; IDA:RGD. DR GO; GO:0005929; C:cilium; ISO:RGD. DR GO; GO:0005829; C:cytosol; ISO:RGD. DR GO; GO:0045121; C:membrane raft; ISO:RGD. DR GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB. DR GO; GO:0005739; C:mitochondrion; IDA:CACAO. DR GO; GO:0032991; C:protein-containing complex; IDA:RGD. DR GO; GO:0097228; C:sperm principal piece; ISO:RGD. DR GO; GO:0005524; F:ATP binding; IDA:RGD. DR GO; GO:0016887; F:ATP hydrolysis activity; IC:RGD. DR GO; GO:0005536; F:D-glucose binding; IDA:RGD. DR GO; GO:0008865; F:fructokinase activity; IDA:UniProtKB. DR GO; GO:0004340; F:glucokinase activity; IDA:UniProtKB. DR GO; GO:0047931; F:glucosamine kinase activity; ISS:UniProtKB. DR GO; GO:0004396; F:hexokinase activity; IDA:CACAO. DR GO; GO:0042802; F:identical protein binding; IPI:RGD. DR GO; GO:0019158; F:mannokinase activity; IDA:UniProtKB. DR GO; GO:0042834; F:peptidoglycan binding; ISO:RGD. DR GO; GO:0004672; F:protein kinase activity; IDA:RGD. DR GO; GO:0061621; P:canonical glycolysis; ISO:RGD. DR GO; GO:0046835; P:carbohydrate phosphorylation; IDA:RGD. DR GO; GO:0006002; P:fructose 6-phosphate metabolic process; IDA:UniProtKB. DR GO; GO:0009298; P:GDP-mannose biosynthetic process; ISO:RGD. DR GO; GO:0051156; P:glucose 6-phosphate metabolic process; IDA:UniProtKB. DR GO; GO:0006006; P:glucose metabolic process; IBA:GO_Central. DR GO; GO:0006096; P:glycolytic process; IDA:RGD. DR GO; GO:0001678; P:intracellular glucose homeostasis; IEA:InterPro. DR GO; GO:0072656; P:maintenance of protein location in mitochondrion; ISO:RGD. DR GO; GO:0006013; P:mannose metabolic process; IDA:UniProtKB. DR GO; GO:1903960; P:negative regulation of anion transmembrane transport; IDA:RGD. DR GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD. DR GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:RGD. DR GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:RGD. DR GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:RGD. DR GO; GO:0002720; P:positive regulation of cytokine production involved in immune response; ISO:RGD. DR GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISO:RGD. DR GO; GO:0046777; P:protein autophosphorylation; IDA:RGD. DR GO; GO:0070585; P:protein localization to mitochondrion; ISO:RGD. DR GO; GO:0006468; P:protein phosphorylation; IDA:RGD. DR GO; GO:0009741; P:response to brassinosteroid; IEP:RGD. DR GO; GO:0001666; P:response to hypoxia; IEP:RGD. DR GO; GO:0002931; P:response to ischemia; IDA:RGD. DR GO; GO:1901986; P:response to ketamine; IEP:RGD. DR CDD; cd24127; ASKHA_NBD_HK1_meta_rpt2; 1. DR FunFam; 3.30.420.40:FF:000015; Hexokinase 1; 2. DR FunFam; 3.40.367.20:FF:000001; Hexokinase 1; 1. DR FunFam; 3.40.367.20:FF:000020; Hexokinase-1; 1. DR Gene3D; 3.30.420.40; -; 2. DR Gene3D; 3.40.367.20; -; 2. DR InterPro; IPR043129; ATPase_NBD. DR InterPro; IPR001312; Hexokinase. DR InterPro; IPR019807; Hexokinase_BS. DR InterPro; IPR022673; Hexokinase_C. DR InterPro; IPR022672; Hexokinase_N. DR PANTHER; PTHR19443; HEXOKINASE; 1. DR PANTHER; PTHR19443:SF80; HEXOKINASE-1; 1. DR Pfam; PF00349; Hexokinase_1; 2. DR Pfam; PF03727; Hexokinase_2; 2. DR PRINTS; PR00475; HEXOKINASE. DR SUPFAM; SSF53067; Actin-like ATPase domain; 4. DR PROSITE; PS00378; HEXOKINASE_1; 2. DR PROSITE; PS51748; HEXOKINASE_2; 2. DR PDBsum; 1BG3; -. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Allosteric enzyme; ATP-binding; Cytoplasm; KW Direct protein sequencing; Glycolysis; Immunity; Inflammatory response; KW Innate immunity; Kinase; Membrane; Mitochondrion; KW Mitochondrion outer membrane; Nucleotide-binding; Phosphoprotein; KW Reference proteome; Repeat; Transferase. FT CHAIN 1..918 FT /note="Hexokinase-1" FT /id="PRO_0000197586" FT DOMAIN 16..458 FT /note="Hexokinase 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01084" FT DOMAIN 464..906 FT /note="Hexokinase 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01084" FT REGION 1..10 FT /note="Mitochondrial-binding peptide (MBP)" FT /evidence="ECO:0000250|UniProtKB:P19367" FT REGION 73..207 FT /note="Hexokinase small subdomain 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01084" FT REGION 208..447 FT /note="Hexokinase large subdomain 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01084" FT REGION 521..655 FT /note="Hexokinase small subdomain 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01084" FT REGION 656..895 FT /note="Hexokinase large subdomain 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01084" FT BINDING 30 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P19367" FT BINDING 84..89 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P19367" FT BINDING 84..88 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 155 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 172..173 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 208..209 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 209 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 232 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 235 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 260 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 291..294 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 413..415 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 425..426 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P19367" FT BINDING 449 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 532..537 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P19367" FT BINDING 532..536 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 603 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 620..621 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 656..657 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 657 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 680 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P19367" FT BINDING 680 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 683 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 708 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 742 FT /ligand="D-glucose" FT /ligand_id="ChEBI:CHEBI:4167" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 747..748 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P19367" FT BINDING 784..788 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P19367" FT BINDING 861..863 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT BINDING 863..867 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P19367" FT BINDING 897 FT /ligand="D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:61548" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:9665168, FT ECO:0007744|PDB:1BG3" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:P19367" FT MOD_RES 337 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT HELIX 2..25 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 27..29 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 33..51 FT /evidence="ECO:0007829|PDB:1BG3" FT TURN 53..55 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 56..58 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 78..96 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 106..108 FT /evidence="ECO:0007829|PDB:1BG3" FT TURN 116..120 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 123..141 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 144..146 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 149..154 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 185..196 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 202..207 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 209..220 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 224..241 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 242..244 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 252..258 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 261..263 FT /evidence="ECO:0007829|PDB:1BG3" FT TURN 264..273 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 276..283 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 285..287 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 294..297 FT /evidence="ECO:0007829|PDB:1BG3" FT TURN 299..301 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 302..315 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 320..322 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 326..329 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 336..342 FT /evidence="ECO:0007829|PDB:1BG3" FT TURN 345..347 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 348..358 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 365..401 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 404..406 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 409..413 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 415..419 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 423..434 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 441..444 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 450..474 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 475..477 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 481..499 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 501..504 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 511..513 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 526..537 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 539..545 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 548..550 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 553..559 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 564..567 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 571..589 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 596..602 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 633..644 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 649..655 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 657..666 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 672..689 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 690..692 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 700..707 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 709..711 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 714..716 FT /evidence="ECO:0007829|PDB:1BG3" FT TURN 717..721 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 724..731 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 733..735 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 740..743 FT /evidence="ECO:0007829|PDB:1BG3" FT TURN 747..749 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 750..763 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 768..770 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 774..777 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 784..790 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 793..795 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 797..806 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 813..848 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 857..861 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 863..867 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 871..882 FT /evidence="ECO:0007829|PDB:1BG3" FT STRAND 889..892 FT /evidence="ECO:0007829|PDB:1BG3" FT HELIX 896..909 FT /evidence="ECO:0007829|PDB:1BG3" SQ SEQUENCE 918 AA; 102408 MW; D2200820F0FC41EE CRC64; MIAAQLLAYY FTELKDDQVK KIDKYLYAMR LSDEILIDIL TRFKKEMKNG LSRDYNPTAS VKMLPTFVRS IPDGSEKGDF IALDLGGSSF RILRVQVNHE KNQNVSMESE IYDTPENIVH GSGTQLFDHV ADCLGDFMEK KKIKDKKLPV GFTFSFPCRQ SKIDEAVLIT WTKRFKASGV EGADVVKLLN KAIKKRGDYD ANIVAVVNDT VGTMMTCGYD DQQCEVGLII GTGTNACYME ELRHIDLVEG DEGRMCINTE WGAFGDDGSL EDIRTEFDRE LDRGSLNPGK QLFEKMVSGM YMGELVRLIL VKMAKEGLLF EGRITPELLT RGKFNTSDVS AIEKDKEGIQ NAKEILTRLG VEPSDVDCVS VQHICTIVSF RSANLVAATL GAILNRLRDN KGTPRLRTTV GVDGSLYKMH PQYSRRFHKT LRRLVPDSDV RFLLSESGTG KGAAMVTAVA YRLAEQHRQI EETLAHFRLS KQTLMEVKKR LRTEMEMGLR KETNSKATVK MLPSFVRSIP DGTEHGDFLA LDLGGTNFRV LLVKIRSGKK RTVEMHNKIY SIPLEIMQGT GDELFDHIVS CISDFLDYMG IKGPRMPLGF TFSFPCHQTN LDCGILISWT KGFKATDCEG HDVASLLRDA VKRREEFDLD VVAVVNDTVG TMMTCAYEEP TCEIGLIVGT GTNACYMEEM KNVEMVEGNQ GQMCINMEWG AFGDNGCLDD IRTDFDKVVD EYSLNSGKQR FEKMISGMYL GEIVRNILID FTKKGFLFRG QISEPLKTRG IFETKFLSQI ESDRLALLQV RAILQQLGLN STCDDSILVK TVCGVVSKRA AQLCGAGMAA VVEKIRENRG LDHLNVTVGV DGTLYKLHPH FSRIMHQTVK ELSPKCTVSF LLSEDGSGKG AALITAVGVR LRGDPSIA //